Approaches to Addressing Hypogammaglobulinemia in Pediatric Patients with Refractory Lupus Nephritis: Emphasizing the Role of Belimumab - Takeaways - MDSpire

Approaches to Addressing Hypogammaglobulinemia in Pediatric Patients with Refractory Lupus Nephritis: Emphasizing the Role of Belimumab

  • By

  • Yanan Han

  • Yanjun Yang

  • Peitong Han

  • Xiaoying Yuan

  • Chunzhen Li

  • Jieyuan Cui

  • April 22, 2026

  • 0 min

Share

  • 1

    Hypogammaglobulinemia was found in 81.5% of pediatric patients with lupus nephritis before treatment initiation.

  • 2

    Belimumab treatment was associated with a higher incidence of infections compared to standard therapy in pediatric lupus nephritis patients.

  • 3

    Patients receiving belimumab had significantly lower serum IgG levels and higher erythrocyte sedimentation rates at certain time points.

  • 4

    Intravenous immunoglobulin therapy was administered to patients with severe infections and low IgG levels during the study.

  • 5

    Monitoring IgG levels is crucial in pediatric lupus nephritis patients treated with belimumab, necessitating aggressive IgG replacement therapy.

Original Source(s)

Approaches to Addressing Hypogammaglobulinemia in Pediatric Patients with Refractory Lupus Nephritis: Emphasizing the Role of Belimumab

  • by Yanan Han, Yanjun Yang, Peitong Han, Xiaoying Yuan, Chunzhen Li, Jieyuan Cui

  • April 22, 2026

Related Content

Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge

Medical Oddities: Can a Home Be Preventive Care?

This week’s medical plot twists involved ants, architecture, and auditory hallucinations.

Restraint care in the pediatric intensive care unit: a qualitative investigation of nurses’ perspectives and experiences